{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:55:15Z","timestamp":1790517315508,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.beha.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T07:15:43Z","timestamp":1478330143000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Splenic marginal zone lymphoma"],"prefix":"10.1016","volume":"30","author":[{"given":"Miguel A.","family":"Piris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantza","family":"Onaind\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.beha.2016.09.005_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.beha.2016.09.005_bib2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199510000-00005","article-title":"Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases","volume":"19","author":"Mollejo","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib4","first-page":"148","article-title":"Splenic lymphoma with circulating villous lymphocytes\/splenic marginal-zone lymphoma","volume":"36","author":"Catovsky","year":"1999","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib5","first-page":"294","article-title":"Splenic B cell lymphoma with \u201cvillous\u201d lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia","volume":"1","author":"Melo","year":"1987","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.beha.2016.09.005_bib6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","article-title":"The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders","volume":"83","author":"Matutes","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC)","volume":"93","author":"Troussard","year":"1996","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2016.09.005_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.leukres.2016.03.005","article-title":"Splenic marginal zone lymphoma: prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era","volume":"44","author":"Perrone","year":"2016","journal-title":"Leukemia Res"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0035-9203(97)90211-X","article-title":"Circulating villous lymphocytes\u2013a link between hyperreactive malarial splenomegaly and splenic lymphoma","volume":"91","author":"Bates","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.beha.2016.09.005_bib12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/his.12092","article-title":"Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases","volume":"62","author":"Traverse-Glehen","year":"2013","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.beha.2016.09.005_bib13","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2016.09.005_bib14","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2016.09.005_bib15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/blood-2013-07-515155","article-title":"Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?","volume":"123","author":"Xochelli","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3109\/10428194.2012.743655","article-title":"Splenic marginal zone lymphoma: a population-based study on the 2001\u20132008 incidence and survival in the United States","volume":"54","author":"Liu","year":"2013","journal-title":"Leukemia Lymphoma"},{"issue":"11","key":"10.1016\/j.beha.2016.09.005_bib17","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1002\/ajh.23314","article-title":"Survival outcomes with and without splenectomy in splenic marginal zone lymphoma","volume":"87","author":"Olszewski","year":"2012","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.beha.2016.09.005_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0046-8177(99)90031-X","article-title":"Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?","volume":"30","author":"Lloret","year":"1999","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.coi.2005.04.009","article-title":"Marginal zone B cells in lymphocyte activation and regulation","volume":"17","author":"Lopes-Carvalho","year":"2005","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000478-199707000-00005","article-title":"Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features","volume":"21","author":"Mollejo","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.beha.2016.09.005_bib21","first-page":"1015","article-title":"Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature","volume":"10","author":"Labouyrie","year":"1997","journal-title":"Mod Patholo Off J U S Can Acad Pathol Inc"},{"issue":"6","key":"10.1016\/j.beha.2016.09.005_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.1996.d01-536.x","article-title":"Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma","volume":"29","author":"Franco","year":"1996","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.beha.2016.09.005_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1532\/IJH97.05017","article-title":"Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report","volume":"81","author":"Kakinoki","year":"2005","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-4608(03)00242-5","article-title":"Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course","volume":"148","author":"Viaggi","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"issue":"18","key":"10.1016\/j.beha.2016.09.005_bib25","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"10","key":"10.1016\/j.beha.2016.09.005_bib26","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/leu.2009.108","article-title":"Identification of MNDA as a new marker for nodal marginal zone lymphoma","volume":"23","author":"Kanellis","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.beha.2016.09.005_bib27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/path.2665","article-title":"Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis","volume":"220","author":"Watkins","year":"2010","journal-title":"J\u00a0Pathol"},{"issue":"9","key":"10.1016\/j.beha.2016.09.005_bib29","doi-asserted-by":"crossref","first-page":"e44997","DOI":"10.1371\/journal.pone.0044997","article-title":"An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma","volume":"7","author":"Watkins","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2008.07176.x","article-title":"Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes","volume":"142","author":"Vega","year":"2008","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.beha.2016.09.005_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.2012.09226.x","article-title":"High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma","volume":"158","author":"Fresquet","year":"2012","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.beha.2016.09.005_bib32","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/sj.leu.2404853","article-title":"MicroRNA losses in the frequently deleted region of 7q in SMZL","volume":"21","author":"Ruiz-Ballesteros","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib33","first-page":"71","article-title":"Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q","volume":"86","author":"Sole","year":"2001","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.beha.2016.09.005_bib34","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2016.09.005_bib35","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","article-title":"p53 abnormalities in splenic lymphoma with villous lymphocytes","volume":"97","author":"Gruszka-Westwood","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2016.09.005_bib36","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.beha.2016.09.005_bib37","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.beha.2016.09.005_bib38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation","volume":"28","author":"Martinez","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.beha.2016.09.005_bib39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2016.09.005_bib41","first-page":"252318","article-title":"CD79B and MYD88 mutations in splenic marginal zone lymphoma","volume":"2013","author":"Troen","year":"2013","journal-title":"ISRN Oncol"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2014.120","article-title":"MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma","volume":"28","author":"Hamadeh","year":"2015","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib43","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V99.4.1299","article-title":"Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course","volume":"99","author":"Algara","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib44","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":"Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib45","first-page":"470","article-title":"Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection","volume":"90","author":"Traverse-Glehen","year":"2005","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.beha.2016.09.005_bib46","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","article-title":"Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis","volume":"106","author":"Ruiz-Ballesteros","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib47","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1525-1578(10)60525-9","article-title":"Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma","volume":"6","author":"Troen","year":"2004","journal-title":"J\u00a0Mol Diagn JMD"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib49","first-page":"889","article-title":"Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling","volume":"26","author":"Arribas","year":"2013","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib50","doi-asserted-by":"crossref","first-page":"e2016006","DOI":"10.4084\/mjhid.2016.006","article-title":"Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy","volume":"8","author":"Perrone","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V93.1.226","article-title":"Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion","volume":"93","author":"Tierens","year":"1999","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2016.09.005_bib52","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma","volume":"8","author":"Parry","year":"2013","journal-title":"PloS One"},{"issue":"1\u20132","key":"10.1016\/j.beha.2016.09.005_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","article-title":"Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes","volume":"40","author":"Lefrere","year":"2000","journal-title":"Leukemia Lymphoma"},{"issue":"8","key":"10.1016\/j.beha.2016.09.005_bib54","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leukemia Lymphoma"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.leu.2401710","article-title":"Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes","volume":"14","author":"Lefrere","year":"2000","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/bjh.12036","article-title":"Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma","volume":"159","author":"Else","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjh.12011","article-title":"Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases","volume":"159","author":"Montalban","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib58","first-page":"601","article-title":"Absence of cyclin D1 protein expression in splenic marginal zone lymphoma","volume":"11","author":"Savilo","year":"1998","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<242::AID-AJH8>3.0.CO;2-A","article-title":"Splenic involvement by blastic mantle cell lymphoma (large cell\/anaplastic variant) mimicking splenic marginal zone lymphoma","volume":"62","author":"Mollejo","year":"1999","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2559.1996.tb01392.x","article-title":"Monocytoid\/marginal zone B-cell differentiation in follicle centre cell lymphoma","volume":"29","author":"Schmid","year":"1996","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2559.1998.00478.x","article-title":"A\u00a0marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma","volume":"33","author":"Piris","year":"1998","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.beha.2016.09.005_bib62","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/00000478-200012000-00001","article-title":"Splenic marginal zone lymphoma with or without plasmacytic differentiation","volume":"24","author":"Duong Van Huyen","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib64","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)64988-7","article-title":"Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas","volume":"156","author":"Remstein","year":"2000","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.beha.2016.09.005_bib65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.pas.0000213419.08009.b0","article-title":"Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases","volume":"31","author":"Papadaki","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib67","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"issue":"71","key":"10.1016\/j.beha.2016.09.005_bib68","first-page":"253","article-title":"Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity","volume":"13","author":"Traverse-Glehen","year":"2012","journal-title":"Discov Med"},{"issue":"7","key":"10.1016\/j.beha.2016.09.005_bib69","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.beha.2016.09.005_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PAS.0000000000000523","article-title":"NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease","volume":"40","author":"Martinez","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"10.1016\/j.beha.2016.09.005_bib72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beha.2016.09.005_bib73","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.beha.2016.09.005_bib74","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/PAS.0b013e318193fcef","article-title":"Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases","volume":"33","author":"Mollejo","year":"2009","journal-title":"Am J Surg Pathol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T15:40:37Z","timestamp":1657640437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692616300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":74,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1521692616300810"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2016.09.005","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenic marginal zone lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}